Year-end Sale % OFF 
Abstract
Background and objectivesThe type 1 interferon signature (IFN1) has been reported in systemic lupus erythematosus (SLE) and subsequently in many other diseases. It is deduced from the expression of a...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
